Clinical trials in transplantation often select outcome measures that are short-term or invalidated. To address this, a number of important initiatives have aimed to develop a core outcome set for trials in kidney transplantation, based on shared priorities of all stakeholders. This masterclass will introduce these initiatives and the importance of their incorporation into clinical studies.
Presentation: Update on the SONG-Tx initiative, Benedicte Sautenet, France
Live Q&A with Benedicte Sautenet, France
Presentation: What has outcome reporting taught us about equity in access to transplantation? Gabriel Oniscu, UK
Live Q&A with Gabriel Oniscu, UK
Masterclass closing remarks